VLDL triglyceride kinetics in lean, overweight, and obese men and women

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 11, 2016, Pages 4151-4160

  Mittendorfer, Bettina ^a   Yoshino, Mihoko ^a   Patterson, Bruce W ^a   Klein, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN TRIGLYCERIDE;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FAT CONTENT; FAT FREE MASS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; KINETICS; LEAN BODY WEIGHT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC CLEARANCE RATE; OBESITY; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN SECRETION; SEX DIFFERENCE; ADIPOSE TISSUE; ADOLESCENT; BLOOD; BODY MASS; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; APOLIPOPROTEIN B-100; BODY MASS INDEX; FEMALE; HUMANS; KINETICS; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; TRIGLYCERIDES; YOUNG ADULT;

EID: 84994905153     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1500     Document Type: Article

References (45)

1. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
2. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86:943-949.
3. EckelRH.Whatis it about very low density lipoproteins(VLDL)and cardiovascular disease in patients with type 2 diabetes mellitus: Is it the triglycerides or the cholesterol? Atherosclerosis. 2014;237:138-139.
4. Sarwar N, Sandhu MS, Ricketts SL, et al. Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies. Lancet. 2010;375:1634-1639.
5. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Int Med. 2003;139:802-809.
6. Converse CA, Skinner ER, eds. Lipoprotein analysis: A practical approach. New York: Oxford University Press; 1992.
7. Gormsen LC, Nellemann B, Sørensen LP, Jensen MD, Christiansen JS, Nielsen S. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab. 2009;296:E165-E173.
8. Mittendorfer B, Patterson BW, Klein S. Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr. 2003;77:573-579.
9. Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49:755-765.
10. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95: 158-166.
11. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106:15430-15435.
12. Søndergaard E, Nellemann B, Sørensen LP, Christensen B, Gormsen LC, Nielsen S. Lean body mass, not FFA, predicts VLDL-TG secretion rate in healthy men. Obesity. 2015;23:1379-1385.
13. Miller BV 3rd, Patterson BW, Okunade A, Klein S. Fatty acid and very low density lipoprotein metabolism in obese African American and Caucasian women with type 2 diabetes. J Lipid Res. 2012;53: 2767-2772.
14. Howard BV, Zech L, Davis M, et al. Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: Lack of influence of body weight or plasma insulin. J Lipid Res. 1980;21:1032-1041.
15. Sumner AE, Furtado JD, Courville AB, et al. ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women. Nutr Metab. 2013; 10:73.
16. Mittendorfer B, Patterson BW, Klein S, Sidossis LS. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: Effects of sex and obesity. Am J Physiol Endocrinol Metab. 2003;284:E708-E715.
17. Magkos F, Wright DC, Patterson BW, Mohammed BS, Mittendorfer B. Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am J Physiol Endocrinol Metab. 2006;290:E355-E362.
18. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab. 2007;92:1311-1318.
19. Mittendorfer B, Patterson BW, Klein S. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab. 2003;284:E549-E556.
20. Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55:1738-1745.
21. Smith GI, Magkos F, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B. One day of mixed meal overfeeding reduces hepatic insulin sensitivity and increases VLDL particle but not VLDL-triglyceride secretion in overweight and obese men. J Clin Endocrinol Metab. 2013;98:3454-3462.
22. Fabbrini E, Mohammed BS, Korenblat KM, et al. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2010;95: 2727-2735.
23. Fabbrini E, Tiemann Luecking C, et al. Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity. Gastroenterology. 2016;150:79-81 e72.
24. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology. 2008;134:424-431.
25. Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab. 2006;291:E1243-E1249.
26. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes. 2003; 52:1641-1648.
27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470.
28. Magkos F, Mittendorfer B. Gender differences in lipid metabolism and the effect of obesity. Obstet Gynecol Clin North Am. 2009;36: 245-265, vii
29. Pedersen SB, Jønler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab. 1994;78:1354-1359.
30. Taskinen MR, Kuusi T. High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity. Atherosclerosis. 1986;59:121-130.
31. Nikkilä EA, Taskinen MR, Rehunen S, Härkönen M. Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteins. Metabolism. 1978;27:1661-1667.
32. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. FASEB J. 1999;13:2051-2060.
33. Smith GI, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B. Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women. J Clin Endocrinol Metab. 2014;99:E1306-E1310.
34. Wang X, Smith GI, Patterson BW, et al. Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab. 2012;302:E740-E746.
35. Fisher RM, Coppack SW, Humphreys SM, Gibbons GF, Frayn KN. Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clin Chim Acta. 1995;236:7-17.
36. Breckenridge WC. The catabolism of very low density lipoproteins. Can J Biochem Cell Biol. 1985;63:890-897.
37. Klein S. The case of visceral fat: Argument for the defense. J Clin Invest. 2004;113:1530-1532.
38. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;113:1582-1588.
39. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab. 2006;91:1446-1452.
40. Marinou K, Adiels M, Hodson L, Frayn KN, Karpe F, Fielding BA. Youngwomenpartition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men. Br J Nutr. 2011;105:857-865.
41. Mittendorfer B, Horowitz JF, Klein S. Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects. Am J Physiol Endocrinol Metab. 2002;283:E58-E65.
42. Sanyal AJ.AGAtechnical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705-1725.
43. Gormsen LC, Jensen MD, Schmitz O, Møller N, Christiansen JS, Nielsen S. Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res. 2006;47:2325-2332.
44. Wolfe RR, Durkot MJ. Role of very low density lipoproteins in the energy metabolism of the rat. J Lipid Res. 1985;26:210-217.
45. Schrauwen P, Wagenmakers AJ, van Marken Lichtenbelt WD, Saris WH, Westerterp KR. Increase in fat oxidation on a high-fat diet is accompanied by an increase in triglyceride-derived fatty acid oxidation. Diabetes. 2000;49:640-646.